1. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (February 2022) Authors: Danese, Silvio; Colombel, Jean-Frederic; Lukas, Milan; Gisbert, Javier P; D'Haens, Geert; Hayee, Bu'hussain; Panaccione, Remo; Kim, Hyun-Soo; Reinisch, Walter; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Tang, Meina Tao; Schreiber, Stefan; Aboo, Nazimuddin; ... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 2(2022) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. GenoType® HelicoDR test in comparison with histology and culture for Helicobacter pylori detection and identification of resistance mutations to clarithromycin and fluoroquinolones. Issue 6 (23rd October 2017) Authors: Pastukh, Nina; Binyamin, Dana; On, Avi; Paritsky, Maya; Peretz, Avi Journal: Helicobacter Issue: Volume 22:Issue 6(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Improvement and optimization of the classical gastric biopsy culture technique forHelicobacter pyloridiagnosis using trypsin. Issue 6 (June 2015) Authors: Peretz, Avi; Paritsky, Maya; Pastukh, Nina; Koifman, Anna; Brodsky, Diana; Glyatman, Tatyana; On, Avi Journal: Journal of medical microbiology Issue: Volume 64:Issue 6(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗